Title: Substrate inhibition in human hydroxysteroid sulfotransferase SULT2A1: studies on the formation of catalytically non-productive enzyme complexes.

Authors: Gulcan, Hayrettin Ozan; Duffel, Michael W

Published In Arch Biochem Biophys, (2011 Mar 15)

Abstract: The cytosolic sulfotransferase hSULT2A1 is the major hydroxysteroid (alcohol) sulfotransferase in human liver, and it catalyzes the 3'-phosphoadenosine-5'-phosphosulfate (PAPS)-dependent sulfation of various endogenous hydroxysteroids as well as many xenobiotics that contain alcohol and phenol functional groups. The hSULT2A1 often displays substrate inhibition, and we have hypothesized that a key element in this response to increasing substrate concentration is the formation of non-productive ternary dead-end enzyme complexes involving the nucleotide product, adenosine 3',5'-diphosphate (PAP). One of these substrates for hSULT2A1 is dehydroepiandrosterone (DHEA), a major circulating steroid hormone in humans that serves as precursor to both androgens and estrogens. We have utilized DHEA in both initial velocity studies and equilibrium binding experiments in order to evaluate the potential role of ternary complexes in substrate inhibition of the enzyme. Our results indicate that hSULT2A1 forms non-productive ternary complexes that involve either DHEA or dehydroepiandrosterone sulfate, and the formation of these ternary complexes displays negative cooperativity in the binding of DHEA.

PubMed ID: 21187059

MeSH Terms: Adenosine Diphosphate/metabolism; Adenosine Diphosphate/pharmacology; Biocatalysis*; Dehydroepiandrosterone/metabolism; Dehydroepiandrosterone/pharmacology; Enzyme Inhibitors/metabolism*; Enzyme Inhibitors/pharmacology*; Humans; Kinetics; Phosphoadenosine Phosphosulfate/metabolism; Phosphoadenosine Phosphosulfate/pharmacology; Protein Binding; Sulfonic Acids/metabolism; Sulfonic Acids/pharmacology; Sulfotransferases/antagonists & inhibitors*; Sulfotransferases/metabolism*